FDA commissioner to visit India as problems pile up; FDA clarifies recall vs. withdrawal;

@EricPFierce: What drugs are up for grabs by generic makers next year? Here's the FiercePharma list of 2014 patent losses. | Follow @EricPFierce

> FDA Commissioner Margaret Hamburg will make her first ever visit to India at a time when the agency has banned a number of its biggest drugmaker for lapses in manufacturing quality. Story

> The pharmaceutical sector accounted for 11% of super-rich Indians, second only to the manufacturing sector, while Dilip Shanghvi of Sun Pharmaceutical broke into the top three among the wealthiest Indians, according to the Hurun India Rich List. More

> The FDA says sometimes a product withdrawal is not a recall. Story

> San Diego, CA-based TriLink BioTechnologies will build a 2,000-square-foot pharmaceutical cGMP production suite with 9 labs in its San Diego facility. Release

And Finally... GlaxoSmithKline ($GSK) will invest £400,000 a year for 10 years in a partnership with Brazil's São Paulo Research Foundation to study ways to reduce the environmental impact of manufacturing drugs as it works to become carbon neutral by 2050. Report